We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options ...
Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
‘The hangover can last longer than the party’: Biotech is in a major slump, with no end in sight
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ascend Wellness Holdings LLC (AAWH – Research ...
Despite posting disappointing top revenue and earnings misses for Q4 last week, Zymeworks (ZYME) has seen its shares rally over 5%, thanks in ...
Assetmark Inc. lowered its position in Genmab A/S (NASDAQ:GMAB – Free Report) by 78.1% during the fourth quarter, Holdings ...
23h
Dealbreaker on MSNBristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio In $286M DealMultiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio ...
NS Partners Ltd reduced its stake in Johnson & Johnson by 3.7%, selling 3,012 shares in Q4. The institutional investor now ...
OFI Invest Asset Management purchased 5,674 shares of Amgen, valued at $1.43 million. Other hedge funds, including Swedbank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results